Arrowhead Research Corporation
Arrowhead Research Corporation reports on new developments
Published in Medical Patent Law Weekly, August 15th, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Arrowhead Research Corporation.
Report 1: Arrowhead Research Corporation, (NASDAQ:ARWR), announced that it has entered into definitive agreements to sell 2,849,446 units consisting of restricted common stock and warrants to purchase restricted common stock to a large institutional money manager, York Capital Management and select accredited investors. Global Crown Capital, LLC acted as the exclusive placement agent for the private placement.
The capital is expected to be...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Patent Law Weekly
More Articles from Medical Patent Law Weekly
- Allergies
Back to School Means Back to Being Sick for Many Students and Teachers - Aortic Dissection
Studies from J. Easo and colleagues yield new information about aortic dissection - Arthritis
Can-Fite: Pre-clinical Studies demonstrate that the Excipients used in the Placebo and CF101 Drug Enhanced the Anti-inflammatory Effect of Methotrexate (MTX) - Arthritis
Cytokine Demonstrates Oral Efficacy of Small-Molecule MIF Inhibitors - Autism
StemCellPatents.com Applauds Stem Cell Clinic for Autism Publication - Biotechnology
New findings reported from G.S. Mcmillan and co-authors describe advances in biotechnology - More from this issue of Medical Patent Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
